Abstract
In contrast to the adult population, many medicines used in children with asthma have been inadequately studied with the result that evidence for their usage is lacking. Short-acting bronchodilators and inhaled corticosteroids have been available for over 40 years and thankfully, evidence for their usage in children is now relatively good. This is not the case for long-acting bronchodilators, leukotriene receptor antagonists and omalizumab. This article discusses currently available evidence on all aspects of treatment relevant to children and offers comments on possible future trends. The development of national and international childrens research networks throughout Europe and beyond should enable robust studies to be undertaken to fill our evidence gap and improve control of asthma in all ages of children.
Keywords: Asthma, bronchodilators
Current Pediatric Reviews
Title: Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?
Volume: 6 Issue: 2
Author(s): Warren Lenney
Affiliation:
Keywords: Asthma, bronchodilators
Abstract: In contrast to the adult population, many medicines used in children with asthma have been inadequately studied with the result that evidence for their usage is lacking. Short-acting bronchodilators and inhaled corticosteroids have been available for over 40 years and thankfully, evidence for their usage in children is now relatively good. This is not the case for long-acting bronchodilators, leukotriene receptor antagonists and omalizumab. This article discusses currently available evidence on all aspects of treatment relevant to children and offers comments on possible future trends. The development of national and international childrens research networks throughout Europe and beyond should enable robust studies to be undertaken to fill our evidence gap and improve control of asthma in all ages of children.
Export Options
About this article
Cite this article as:
Lenney Warren, Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?, Current Pediatric Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339610791561169
DOI https://dx.doi.org/10.2174/157339610791561169 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evaluation of B Lymphocyte Deficiencies
Cardiovascular & Hematological Disorders-Drug Targets Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery The Role of Neurotrophins in Inflammation and Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Genetic Dissection of Complex Traits In Silico: Approaches, Problems and Solutions
Current Bioinformatics The Potential Clinical Properties of Magnesium
Current Medicinal Chemistry Edtorial [Hot topic: Glucocorticoids from Chemistry to Clinics (Executive Editor: Fortunato Vesce)]
Current Pharmaceutical Design Recent Advances in Ozonation of Vegetable Oils
Recent Patents on Materials Science Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS
Current Medicinal Chemistry Complications Following Stem Cell Therapy in Inflammatory Bowel Disease
Current Stem Cell Research & Therapy Climate Changes and Human Health: A Review of the Effect of Environmental Stressors on Cardiovascular Diseases Across Epidemiology and Biological Mechanisms
Current Pharmaceutical Design Antibiotic Potentiation of Natural Products: A Promising Target to Fight Pathogenic Bacteria
Current Drug Targets EGF and PDGF Receptor Tyrosine Kinases as Therapeutic Targets for Chronic Lung Diseases
Current Molecular Medicine Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease
Current Medicinal Chemistry The Need to Consider Context in the Evaluation of Anti-infectious and Immunomodulatory Effects of Vitamin A and its Derivatives
Current Drug Targets Ciclesonide - A Novel Corticosteroid for the Management of Asthma
Current Clinical Pharmacology Association of Wheat Allergy and Coeliac Disease through Pediatric and Adult Age: A Review of Literature
Current Nutrition & Food Science Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases
Current Pharmaceutical Design Premenstrual Asthma: A Myth or a Reality?
Current Respiratory Medicine Reviews B-Cell Based Gene Therapy for Autoimmune Diseases
Infectious Disorders - Drug Targets